Rocuronium Dose Comparison for Prostate Cancer Surgery

"intubation (procedure), muscular fasciculation, and curarization therapy can all be effectively treated by using Rocuronium 1.5mg/kg/hr."

"Currently, there are 16 ongoing studies evaluating the effects of Rocuronium 1.5mg/kg/hr with 3 Phase 3 trials underway. Of the 29 total clinical trial sites for Rocuronium 1.5mg/kg/hr, several are based in Montreal, Quebec."

"Data shows that there are 16 different ongoing clinical trials for Rocuronium 1.5mg/kg/hr in 11 cities and 10 countries. The first ever trial of its kind was completed in 2009 by Medtronic - MITG. That particular study had 80 participants and finished its N/A drug approval stage. In the last 12 years, 135 similar trials have been conducted."

"This particular clinical trial is looking for 130 patients that have prostate cancer and are between 18-80 years old. Other requirements include being an adult under 80 years old who will be undergoing surgery at Josie Robertson Surgical Center."

"Rocuronium 1.5mg/kg/hr is estimated to be a 2 in terms of safety by our team because it is in Phase 2 of clinical trials. This lack of efficacy data means that, while some safety data exists, there is none to support its use as an effective medication."

"Yes, according to the information displayed on clinicaltrials.gov, this study is still recruiting patients. The trial was originally posted on 1/14/2019 and was last updated on 7/12/2022. Currently, the research team is looking for 130 individuals who are willing to participate at one of two locations."

"The age limit for this particular clinical trial is 18 to 80 years old. There are a total of 85 trials for patients that meet the under-18 criteria and 1,371 trials for people who exceed 65 years of age."

"Yes, as the clinicaltrials.gov website reports, this trial is open and actively recruiting participants. The study was posted on January 14th, 2019 and was last edited on July 12th, 2022."